Quốc gia: Đức Sàn giao dịch: Frankfurt Khu vực: Chăm sóc sức khỏe Ngành: Công nghệ sinh học Thị trường chứng khoán - Báo giá & giá
Danh sách tất cả các chứng khoán và vốn chủ sở hữu kèm giá, vốn hoá thị trường, PE và EPS
Đức (648)
- {{country.name}}
- Tất cả các quốc gia
- Đức (648)
Frankfurt (648)
Chăm sóc sức khỏe (648)
- {{item.name}}
- Tất cả các khối
- Chăm sóc sức khỏe (648)
Công nghệ sinh học (648)
- {{item.name}}
- Tất cả các ngành
- Công nghệ sinh học (648)
- Nhà sản xuất thuốc - Chung (45)
- Nhà sản xuất thuốc - Biệt dược & Thuốc gốc (276)
- Gói y tế (9)
- Cơ sơ chăm sóc y tế (93)
- Nhà bán lẻ thuốc (21)
- Dịch vụ thông tin sức khỏe (81)
- Thiết bị y tế (201)
- Thiết bị & nguồn cung y tế (106)
- Chẩn đoán & nghiên cứu (101)
- Phân phối y tế (22)
Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS |
---|
Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS | |
---|---|---|---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
Novavax, Inc. NVV1.F | $12.16 13.29 USD |
-9.02
|
$1.79B 1.96B USD | $18.75K 20.5K USD | $11.92 13.03 USD | $13.49 14.74 USD | $1.79B 1.96B USD | 0 | -$2.81 -3.07 USD | |
CureVac N.V. 5CV.F | $3.19 3.48 USD |
+1.14
|
$720.34M 787.43M USD | $130.98K 143.18K USD | $3.19 3.48 USD | $3.58 3.92 USD | $720.34M 787.43M USD | 0 | -$1.18 -1.2 USD | |
Valneva SE AYJ.F | $4.1 4.49 USD |
+0.74
|
$571.08M 624.27M USD | $2.74K 3K USD | $4.04 4.42 USD | $4.14 4.53 USD | $571.08M 624.27M USD | 0 | -$0.19 -0.2 USD | |
Ocugen, Inc. 2H51.F | $1.75 1.91 USD |
-3.1
|
$452.27M 494.39M USD | $9.03K 9.88K USD | $1.75 1.91 USD | $1.83 2 USD | $452.27M 494.39M USD | 0 | -$0.21 -0.2 USD | |
Cybin Inc. R7E1.F | $0.33 0.36 USD |
+0.49
|
$248.42M 271.56M USD | $3K 3.28K USD | $0.2999 0.33 USD | $0.33 0.36 USD | $248.42M 271.56M USD | 0 | -$0.2 -0.2 USD | |
Sernova Corp. PSH.F | $0.2099 0.23 USD |
-14.85
|
$65.62M 71.73M USD | $1K 1.09K USD | $0.2099 0.23 USD | $0.2099 0.23 USD | $65.62M 71.73M USD | 0 | -$0.09 -0.09 USD | |
Defence Therapeutics Inc. DTC.F | $0.79 0.86 USD |
-11.83
|
$37.16M 40.62M USD | $13.15K 14.37K USD | $0.79 0.86 USD | $0.8499 0.93 USD | $37.16M 40.62M USD | 0 | -$0.13 -0.1 USD | |
IntelGenx Technologies Corp. 0IL.F | $0.14 0.16 USD |
+20.17
|
$26.84M 29.34M USD | $140K 153.04K USD | $0.14 0.16 USD | $0.14 0.16 USD | $26.84M 29.34M USD | 0 | -$0.06 -0.06 USD | |
Vivoryon Therapeutics N.V. 05Y.F | $0.81 0.89 USD |
+9.56
|
$21.22M 23.19M USD | $2.43K 2.65K USD | $0.7299 0.8 USD | $0.81 0.89 USD | $21.22M 23.19M USD | 0 | -$1.12 -1.2 USD | |
Alterity Therapeutics Limited PBN.F | $0.0015 0.0016 USD |
0
|
$16.1M 17.6M USD | $300 327.94 USD | $0.0015 0.0016 USD | $0.0015 0.0016 USD | $16.1M 17.6M USD | 0 | $0 0 USD | |
Sirona Biochem Corp. ZSB.F | $0.04 0.04 USD |
+11.11
|
$10.35M 11.31M USD | $37K 40.45K USD | $0.04 0.04 USD | $0.04 0.04 USD | $10.35M 11.31M USD | 0 | $0 0 USD | |
BioVaxys Technology Corp. 5LB.F | $0.04 0.04 USD |
0
|
$7.31M 7.99M USD | $20K 21.86K USD | $0.04 0.04 USD | $0.04 0.04 USD | $7.31M 7.99M USD | 0 | -$0.08 -0.08 USD | |
Core One Labs Inc. LD6.F | $0.1199 0.13 USD |
-5.12
|
$5.89M 6.44M USD | $111 121.34 USD | $0.1199 0.13 USD | $0.1199 0.13 USD | $5.89M 6.44M USD | 0 | -$0.07 -0.07 USD | |
Cyxone AB (publ) 4CX.F | $0.0054 0.0059 USD |
+12.5
|
$2.64M 2.89M USD | $10K 10.93K USD | $0.003 0.0032 USD | $0.0054 0.0059 USD | $2.64M 2.89M USD | 0 | -$0.02 -0.02 USD | |
Oxurion NV TG4.F | $0.0001 0.00010 USD |
0
|
$2.02M 2.21M USD | $2.5K 2.73K USD | $0.0001 0.00010 USD | $0.0001 0.00010 USD | $2.02M 2.21M USD | 0 | -$0.01 -0.01 USD | |
RVL Pharmaceuticals plc O1P.F | $0.003 0.0032 USD |
0
|
$1.9M 2.07M USD | $1 1.09 USD | $0.003 0.0032 USD | $0.003 0.0032 USD | $1.9M 2.07M USD | 0 | -$0.67 -0.7 USD | |
Braxia Scientific Corp. 4960.F | $0.005 0.0054 USD |
0
|
$1.42M 1.55M USD | $43.47K 47.51K USD | $0.005 0.0054 USD | $0.005 0.0054 USD | $1.42M 1.55M USD | 0 | -$0.03 -0.03 USD | |
Amniotics AB (publ) 66J.F | $0.0002 0.00021 USD |
0
|
$915.01K 1M USD | $100K 109.31K USD | $0.0002 0.00021 USD | $0.0002 0.00021 USD | $915.01K 1M USD | 0 | -$0.01 -0.01 USD | |
Bioasis Technologies Inc. 107.F | $0.008 0.0087 USD |
0
|
$635.31K 694.48K USD | $180K 196.76K USD | $0.005 0.0054 USD | $0.008 0.0087 USD | $635.31K 694.48K USD | 0 | -$0.03 -0.03 USD | |
Novo Nordisk A/S NOVA.F | $121.5 132.82 USD |
-0.82
|
$541.26B 591.67B USD | $1.36K 1.49K USD | $121 132.27 USD | $123.5 135 USD | $541.26B 591.67B USD | 45.50 | $2.67 2.92 USD | |
Vertex Pharmaceuticals Incorporated VX1.F | $407.15 445.07 USD |
+1.02
|
$105.72B 115.56B USD | $88 96.2 USD | $404.9 442.61 USD | $407.75 445.73 USD | $105.72B 115.56B USD | 28.73 | $14.17 15.49 USD | |
CSL Limited CSJA.F | $84.5 92.37 USD |
-2.87
|
$83.19B 90.93B USD | $10 10.93 USD | $84.5 92.37 USD | $84.5 92.37 USD | $83.19B 90.93B USD | 36.11 | $2.34 2.56 USD | |
CSL Limited CSJ.F | $169.7 185.51 USD |
-2.82
|
$83.19B 90.93B USD | $10 10.93 USD | $169.7 185.51 USD | $169.7 185.51 USD | $83.19B 90.93B USD | 36.26 | $4.68 5.12 USD | |
Moderna, Inc. 0QF.F | $122.14 133.52 USD |
+0.11
|
$46.87B 51.23B USD | $387 423.04 USD | $121.22 132.51 USD | $122.76 134.19 USD | $46.87B 51.23B USD | 0 | -$14.34 -15.6 USD | |
Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
UCB SA UNC.F | $121 132.27 USD |
-1.35
|
$23.67B 25.87B USD | $40 43.73 USD | $121 132.27 USD | $121 132.27 USD | $23.67B 25.87B USD | 69.14 | $1.75 1.91 USD | |
UCB SA UNC0.F | $60.5 66.13 USD |
0
|
$23.67B 25.87B USD | $4 4.37 USD | $60.5 66.13 USD | $60.5 66.13 USD | $23.67B 25.87B USD | 68.75 | $0.88 0.96 USD | |
argenx SE 1AE.F | $344.8 376.91 USD |
+0.58
|
$20.49B 22.4B USD | $2 2.19 USD | $344.8 376.91 USD | $344.8 376.91 USD | $20.49B 22.4B USD | 0 | -$5.24 -5.7 USD | |
argenx SE 1AEA.F | $342 373.85 USD |
0
|
$20.33B 22.22B USD | $10 10.93 USD | $342 373.85 USD | $342 373.85 USD | $20.33B 22.22B USD | 0 | -$5.23 -5.7 USD | |
BioNTech SE 22UA.F | $82.75 90.46 USD |
-2.24
|
$20.09B 21.96B USD | $511 558.59 USD | $82.75 90.46 USD | $85.95 93.95 USD | $20.09B 21.96B USD | 176.06 | $0.47 0.51 USD | |
BeiGene, Ltd. 49BA.F | $156 170.53 USD |
+0.65
|
$17.69B 19.34B USD | $20 21.86 USD | $155 169.44 USD | $156 170.53 USD | $17.69B 19.34B USD | 0 | -$6.94 -7.5 USD | |
Alnylam Pharmaceuticals, Inc. DUL.F | $136.9 149.65 USD |
+1.78
|
$17.39B 19.01B USD | $30 32.79 USD | $136.9 149.65 USD | $138.1 150.96 USD | $17.39B 19.01B USD | 0 | -$2.42 -2.6 USD | |
BeiGene, Ltd. 49B.F | $11.9 13.01 USD |
+0.85
|
$17.16B 18.75B USD | $340 371.67 USD | $11.9 13.01 USD | $11.9 13.01 USD | $17.16B 18.75B USD | 0 | -$0.53 -0.5 USD | |
Royalty Pharma plc RPD.F | $24.84 27.15 USD |
-2.4
|
$14.99B 16.39B USD | $30 32.79 USD | $24.84 27.15 USD | $25.42 27.79 USD | $14.99B 16.39B USD | 15.14 | $1.64 1.79 USD | |
BioMarin Pharmaceutical Inc. BM8.F | $70 76.52 USD |
-5.56
|
$13.55B 14.81B USD | $100 109.31 USD | $70 76.52 USD | $70 76.52 USD | $13.55B 14.81B USD | 72.16 | $0.97 1.06 USD | |
Bio-Techne Corporation TE1.F | $75.5 82.53 USD |
-0.66
|
$12.15B 13.28B USD | $2 2.19 USD | $75.5 82.53 USD | $75.5 82.53 USD | $12.15B 13.28B USD | 65.65 | $1.15 1.26 USD | |
Incyte Corporation ICY.F | $52.1 56.95 USD |
+0.19
|
$11.81B 12.91B USD | $140 153.04 USD | $52.1 56.95 USD | $52.24 57.11 USD | $11.81B 12.91B USD | 17.13 | $3.04 3.32 USD | |
Sarepta Therapeutics, Inc. AB3A.F | $121.8 133.14 USD |
+0.5
|
$11.51B 12.59B USD | $4 4.37 USD | $121.6 132.93 USD | $121.8 133.14 USD | $11.51B 12.59B USD | 312.30 | $0.39 0.43 USD | |
United Therapeutics Corporation UTH.F | $248.9 272.08 USD |
-0.04
|
$11.2B 12.24B USD | $15 16.4 USD | $248.9 272.08 USD | $248.9 272.08 USD | $11.2B 12.24B USD | 12.80 | $19.44 21.25 USD | |
Roivant Sciences Ltd. 87S.F | $10.06 11 USD |
-0.84
|
$8.33B 9.1B USD | $1K 1.09K USD | $10.02 10.95 USD | $10.06 11 USD | $8.33B 9.1B USD | 2.07 | $4.85 5.3 USD | |
ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
Innovent Biologics, Inc. 6IB.F | $4.68 5.12 USD |
+0.86
|
$7.66B 8.37B USD | $520 568.43 USD | $4.68 5.12 USD | $4.68 5.12 USD | $7.66B 8.37B USD | 0 | -$0.08 -0.08 USD | |
Legend Biotech Corporation 9LB.F | $41.2 45.04 USD |
-2.37
|
$7.57B 8.28B USD | $20 21.86 USD | $41.2 45.04 USD | $42.4 46.35 USD | $7.57B 8.28B USD | 0 | -$2.37 -2.5 USD | |
Vaxcyte, Inc. 5VA.F | $68.5 74.88 USD |
+4.58
|
$7.47B 8.16B USD | $4 4.37 USD | $68.5 74.88 USD | $68.5 74.88 USD | $7.47B 8.16B USD | 0 | -$3.95 -4.3 USD | |
WuXi Biologics (Cayman) Inc. 1FW2.F | $1.67 1.83 USD |
-3.19
|
$6.96B 7.61B USD | $710 776.13 USD | $1.64 1.79 USD | $1.67 1.83 USD | $6.96B 7.61B USD | 16.74 | $0.1 0.11 USD | |
Viking Therapeutics, Inc. 1VT.F | $63.02 68.89 USD |
-0.19
|
$6.95B 7.6B USD | $2.09K 2.28K USD | $63.38 69.28 USD | $66.76 72.98 USD | $6.95B 7.6B USD | 0 | -$0.84 -0.9 USD | |
WuXi Biologics (Cayman) Inc. 1FW1.F | $3.18 3.48 USD |
-3.64
|
$6.9B 7.54B USD | $1.05K 1.14K USD | $3.18 3.48 USD | $3.18 3.48 USD | $6.9B 7.54B USD | 15.90 | $0.2 0.22 USD | |
Sino Biopharmaceutical Limited SMZ1.F | $0.3599 0.39 USD |
-1.08
|
$6.85B 7.49B USD | $1.4K 1.53K USD | $0.3599 0.39 USD | $0.3599 0.39 USD | $6.85B 7.49B USD | 35.60 | $0.01 0.01 USD | |
Ascendis Pharma A/S A71.F | $113 123.52 USD |
-0.88
|
$6.45B 7.05B USD | $1K 1.09K USD | $113 123.52 USD | $113 123.52 USD | $6.45B 7.05B USD | 0 | -$8.87 -9.6 USD | |
Jazz Pharmaceuticals plc J7Z.F | $99.6 108.88 USD |
-1.43
|
$6.32B 6.91B USD | $5 5.47 USD | $99.6 108.88 USD | $102.4 111.94 USD | $6.32B 6.91B USD | 22.43 | $4.44 4.85 USD | |
Blueprint Medicines Corporation 2L9.F | $97.2 106.25 USD |
-0.51
|
$6.09B 6.65B USD | $63 68.87 USD | $96.72 105.73 USD | $97.22 106.27 USD | $6.09B 6.65B USD | 0 | -$4.43 -4.8 USD | |
Revolution Medicines, Inc. 42Z.F | $35.8 39.13 USD |
-0.56
|
$5.98B 6.54B USD | $30 32.79 USD | $35.8 39.13 USD | $35.8 39.13 USD | $5.98B 6.54B USD | 0 | -$3.53 -3.8 USD | |
Cytokinetics, Incorporated KK3A.F | $55 60.12 USD |
0
|
$5.77B 6.3B USD | $200 218.63 USD | $55 60.12 USD | $55 60.12 USD | $5.77B 6.3B USD | 0 | -$4.97 -5.4 USD | |
Exelixis, Inc. EX9.F | $18.92 20.68 USD |
-1.64
|
$5.6B 6.13B USD | $505 552.03 USD | $18.92 20.68 USD | $19.66 21.49 USD | $5.6B 6.13B USD | 31.52 | $0.6 0.66 USD | |
Halozyme Therapeutics, Inc. RV7.F | $41.6 45.47 USD |
-0.86
|
$5.29B 5.79B USD | $5 5.47 USD | $41.6 45.47 USD | $41.6 45.47 USD | $5.29B 5.79B USD | 18.73 | $2.22 2.43 USD | |
BridgeBio Pharma, Inc. 2CL.F | $27.79 30.38 USD |
+1.09
|
$5.2B 5.68B USD | $300 327.94 USD | $27.79 30.38 USD | $28.34 30.98 USD | $5.2B 5.68B USD | 0 | -$2.97 -3.2 USD | |
Ionis Pharmaceuticals, Inc. ISI.F | $34.46 37.67 USD |
-1.51
|
$5.03B 5.5B USD | $1.2K 1.31K USD | $34.46 37.67 USD | $34.46 37.67 USD | $5.03B 5.5B USD | 0 | -$2.46 -2.6 USD | |
Akeso, Inc. 4RY.F | $5.7 6.23 USD |
-1.72
|
$4.97B 5.44B USD | $351 383.69 USD | $5.7 6.23 USD | $5.8 6.34 USD | $4.97B 5.44B USD | 18.38 | $0.31 0.34 USD | |
ImmunityBio, Inc. 26CA.F | $6.99 7.64 USD |
-1.58
|
$4.87B 5.32B USD | $1.32K 1.44K USD | $6.89 7.53 USD | $7.08 7.74 USD | $4.87B 5.32B USD | 0 | -$0.99 -1.08 USD | |
Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
Apellis Pharmaceuticals, Inc. 1JK.F | $37.97 41.51 USD |
-1.21
|
$4.61B 5.04B USD | $20 21.86 USD | $37.97 41.51 USD | $37.97 41.51 USD | $4.61B 5.04B USD | 0 | -$3.16 -3.4 USD | |
ALK-Abelló A/S 4AJ0.F | $20.54 22.45 USD |
+0.2
|
$4.51B 4.93B USD | $2.16K 2.36K USD | $20.54 22.45 USD | $20.54 22.45 USD | $4.51B 4.93B USD | 58.68 | $0.35 0.38 USD | |
Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $85.4 93.35 USD |
-0.35
|
$4.42B 4.83B USD | $400 437.25 USD | $85.4 93.35 USD | $85.4 93.35 USD | $4.42B 4.83B USD | 32.97 | $2.59 2.83 USD | |
Financière de Tubize SA FTD.F | $94.8 103.63 USD |
-0.32
|
$4.32B 4.72B USD | $4 4.37 USD | $94.8 103.63 USD | $94.8 103.63 USD | $4.32B 4.72B USD | 47.87 | $1.98 2.16 USD | |
Madrigal Pharmaceuticals, Inc. YDO1.F | $201.6 220.38 USD |
+2.15
|
$4.32B 4.72B USD | $10 10.93 USD | $196.7 215.02 USD | $201.6 220.38 USD | $4.32B 4.72B USD | 0 | -$21.28 -23.2 USD | |
Krystal Biotech, Inc. 4KB.F | $149.8 163.75 USD |
+0.5
|
$4.31B 4.71B USD | $7 7.65 USD | $149.8 163.75 USD | $149.8 163.75 USD | $4.31B 4.71B USD | 74.52 | $2.01 2.2 USD | |
Alpine Immune Sciences, Inc. 34LA.F | $59 64.49 USD |
0
|
$4.1B 4.48B USD | $20 21.86 USD | $59 64.49 USD | $59 64.49 USD | $4.1B 4.48B USD | 0 | -$0.59 -0.6 USD | |
Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
Crinetics Pharmaceuticals, Inc. 6Z4.F | $47.6 52.03 USD |
+3.03
|
$3.75B 4.1B USD | $40 43.73 USD | $47.6 52.03 USD | $47.6 52.03 USD | $3.75B 4.1B USD | 0 | -$3.47 -3.7 USD | |
Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | $7.2 7.87 USD |
-1.37
|
$3.73B 4.08B USD | $56 61.22 USD | $7.2 7.87 USD | $7.2 7.87 USD | $3.73B 4.08B USD | 10.58 | $0.68 0.74 USD | |
CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
Insmed Incorporated IM8N.F | $23 25.14 USD |
0
|
$3.42B 3.74B USD | $25 27.33 USD | $23 25.14 USD | $23 25.14 USD | $3.42B 3.74B USD | 0 | -$4.81 -5.2 USD | |
Axsome Therapeutics, Inc. 19X.F | $70.36 76.91 USD |
+2.06
|
$3.35B 3.66B USD | $200 218.63 USD | $70.36 76.91 USD | $70.36 76.91 USD | $3.35B 3.66B USD | 0 | -$5.94 -6.4 USD | |
Ultragenyx Pharmaceutical Inc. UP0.F | $39.2 42.85 USD |
+3.7
|
$3.26B 3.56B USD | $100 109.31 USD | $39.2 42.85 USD | $39.2 42.85 USD | $3.26B 3.56B USD | 0 | -$7.31 -7.9 USD | |
Genscript Biotech Corporation G51.F | $1.43 1.56 USD |
-2.05
|
$3.1B 3.39B USD | $900 983.82 USD | $1.43 1.56 USD | $1.43 1.56 USD | $3.1B 3.39B USD | 0 | -$0.04 -0.04 USD | |
IDEAYA Biosciences, Inc. 30J.F | $37.6 41.1 USD |
-2.08
|
$2.85B 3.11B USD | $420 459.12 USD | $37.6 41.1 USD | $37.6 41.1 USD | $2.85B 3.11B USD | 0 | -$1.84 -2.01 USD | |
Arrowhead Pharmaceuticals, Inc. HDP1.F | $22.84 24.97 USD |
-0.04
|
$2.84B 3.1B USD | $20 21.86 USD | $22.84 24.97 USD | $22.84 24.97 USD | $2.84B 3.1B USD | 0 | -$3.89 -4.2 USD | |
Xenon Pharmaceuticals Inc. XP0.F | $37 40.45 USD |
0
|
$2.79B 3.05B USD | $20 21.86 USD | $37 40.45 USD | $37 40.45 USD | $2.79B 3.05B USD | 0 | -$2.5 -2.7 USD | |
Camurus AB (publ) 7CA.F | $47.76 52.21 USD |
-1.77
|
$2.78B 3.03B USD | $40 43.73 USD | $47.76 52.21 USD | $47.76 52.21 USD | $2.78B 3.03B USD | 71.28 | $0.67 0.73 USD | |
Denali Therapeutics Inc. 4DN.F | $18.52 20.24 USD |
-2.32
|
$2.69B 2.94B USD | $100 109.31 USD | $18.52 20.24 USD | $18.52 20.24 USD | $2.69B 2.94B USD | 0 | -$0.86 -0.9 USD | |
Corcept Therapeutics Incorporated HTD.F | $25.05 27.38 USD |
-0.83
|
$2.69B 2.94B USD | $50 54.66 USD | $25.05 27.38 USD | $25.05 27.38 USD | $2.69B 2.94B USD | 25.82 | $0.97 1.06 USD | |
Iovance Biotherapeutics, Inc. 2LB.F | $9.59 10.49 USD |
-2.24
|
$2.68B 2.93B USD | $501 547.66 USD | $9.59 10.49 USD | $9.59 10.49 USD | $2.68B 2.93B USD | 0 | -$1.67 -1.8 USD | |
Maravai LifeSciences Holdings, Inc. MAR.F | $10.3 11.26 USD |
+0.98
|
$2.62B 2.87B USD | $25 27.33 USD | $10.1 11.04 USD | $10.5 11.48 USD | $2.62B 2.87B USD | 0 | -$0.91 -0.9 USD | |
MorphoSys AG MOR2.F | $17.3 18.91 USD |
+1.76
|
$2.62B 2.86B USD | $100 109.31 USD | $17.3 18.91 USD | $17.3 18.91 USD | $2.62B 2.86B USD | 0 | -$1.38 -1.5 USD | |
MorphoSys AG MOR.F | $69.35 75.81 USD |
-0.64
|
$2.62B 2.86B USD | $1.03K 1.12K USD | $69.1 75.54 USD | $69.95 76.46 USD | $2.62B 2.86B USD | 0 | -$5.53 -6.04 USD | |
Amicus Therapeutics, Inc. AM6.F | $8.65 9.46 USD |
-2.26
|
$2.61B 2.85B USD | $850 929.16 USD | $8.65 9.46 USD | $8.65 9.46 USD | $2.61B 2.85B USD | 0 | -$0.45 -0.4 USD | |
TG Therapeutics, Inc. NKB2.F | $15.89 17.37 USD |
-1.6
|
$2.46B 2.68B USD | $215 235.02 USD | $15.89 17.37 USD | $15.89 17.37 USD | $2.46B 2.68B USD | 56.74 | $0.28 0.31 USD | |
Immunocore Holdings plc 6YG.F | $48.8 53.34 USD |
-2.01
|
$2.45B 2.68B USD | $100 109.31 USD | $48.8 53.34 USD | $49.4 54 USD | $2.45B 2.68B USD | 0 | -$1.42 -1.5 USD | |
Celldex Therapeutics, Inc. TCE2.F | $36.4 39.79 USD |
0
|
$2.4B 2.62B USD | $85 92.92 USD | $36.4 39.79 USD | $36.4 39.79 USD | $2.4B 2.62B USD | 0 | -$2.63 -2.8 USD | |
Merus N.V. 2GH.F | $39.4 43.07 USD |
-3.9
|
$2.37B 2.59B USD | $105 114.78 USD | $39.4 43.07 USD | $40.8 44.6 USD | $2.37B 2.59B USD | 0 | -$2.51 -2.7 USD | |
Intellia Therapeutics, Inc. 38I.F | $23.68 25.89 USD |
-0.13
|
$2.33B 2.54B USD | $90 98.38 USD | $23.68 25.89 USD | $24.89 27.21 USD | $2.33B 2.54B USD | 0 | -$4.94 -5.4 USD | |
BB Biotech AG Ord BBZA.F | $42 45.91 USD |
-2.21
|
$2.3B 2.52B USD | $6.76K 7.38K USD | $42 45.91 USD | $43 47 USD | $2.3B 2.52B USD | 0 | -$3.84 -4.1 USD | |
ACADIA Pharmaceuticals Inc. DR6.F | $13.58 14.84 USD |
-1.7
|
$2.25B 2.46B USD | $260 284.22 USD | $13.58 14.84 USD | $13.58 14.84 USD | $2.25B 2.46B USD | 0 | $0 0 USD | |
Rhythm Pharmaceuticals, Inc. 1RV.F | $35.6 38.92 USD |
-1.11
|
$2.17B 2.37B USD | $50 54.66 USD | $35.6 38.92 USD | $35.8 39.13 USD | $2.17B 2.37B USD | 0 | -$4.26 -4.6 USD | |
Vericel Corporation ATQP.F | $43.4 47.44 USD |
-3.56
|
$2.16B 2.36B USD | $10 10.93 USD | $43.4 47.44 USD | $43.4 47.44 USD | $2.16B 2.36B USD | 4340.00 | $0.01 0.01 USD | |
Geron Corporation GON.F | $3.54 3.87 USD |
+0.03
|
$2.1B 2.3B USD | $400 437.25 USD | $3.54 3.87 USD | $3.54 3.87 USD | $2.1B 2.3B USD | 0 | -$0.32 -0.3 USD | |
Rocket Pharmaceuticals, Inc. 9IP1.F | $21.51 23.51 USD |
-0.46
|
$1.95B 2.13B USD | $120 131.18 USD | $21.51 23.51 USD | $21.51 23.51 USD | $1.95B 2.13B USD | 0 | -$2.62 -2.8 USD | |
Bavarian Nordic A/S BV3.F | $24.04 26.28 USD |
+3.98
|
$1.87B 2.05B USD | $55 60.12 USD | $24.04 26.28 USD | $24.04 26.28 USD | $1.87B 2.05B USD | 14.22 | $1.69 1.85 USD | |
Agios Pharmaceuticals, Inc. 8AP.F | $32.2 35.2 USD |
0
|
$1.83B 2B USD | $100 109.31 USD | $32.2 35.2 USD | $32.2 35.2 USD | $1.83B 2B USD | 0 | -$5.81 -6.3 USD | |
Galapagos NV GXE.F | $27.64 30.21 USD |
+1.92
|
$1.82B 1.99B USD | $400 437.25 USD | $27.64 30.21 USD | $28.32 30.96 USD | $1.82B 1.99B USD | 58.80 | $0.47 0.51 USD | |
Không có cổ phiếu ưa thích
Bạn chưa có cổ phiếu ưa thích nào, hãy thêm nó vào mục ưa thích để thấy nó tại đây |